Regulatory role of C5a on macrophage migration inhibitory factor release from neutrophils

Journal of Immunology

Volumn 173, Issue 2, 2004, Pages 1355-1359

  Riedemann, Niels C ^a   Guo, Ren Feng ^a   Gao, Hongwei ^a   Sun, Lei ^a   Hoesel, Marco ^a   Hollmann, Travis J ^b   Wetsel, Rick A ^b   Zetoune, Firas S ^a   Ward, Peter A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; MIGRATION INHIBITION FACTOR; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CECUM; CELL GRANULE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INTESTINE PERFORATION; LIGATION; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SEPSIS;

EID: 3142703604     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.2.1355     Document Type: Article

References (29)

1. David, J. R. 1966. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Natl. Acad. Sci. USA 56:72.
2. Bernhagen, J., T. Calandra, R. A. Mitchell, S. B. Martin, K. J. Tracey, W. Voelter, K. R. Manogue, A. Cerami, and R. Bucala. 1993. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365:756.
3. Calandra, T., J. Bernhagen, R. A. Mitchell, and R. Bucala. 1994. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med. 179:1895.
4. Rossi, A. G., C. Haslett, N. Hirani, A. P. Greening, I. Rahman, C. N. Metz, R. Bucala, and S. C. Donnelly. 1998. Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF): potential role in asthma. J. Clin. Invest. 101:2869.
5. Rice, E. K., G. H. Tesch, Z. Cao, M. E. Cooper, C.N. Metz, R. Bucala, R. C. Atkins, and D. J. Nikolic-Paterson. 2003. Induction of MIF synthesis and secretion by tubular epithelial cells: a novel action of angiotensin II. Kidney Int. 63:1265.
6. Arndt, U., G. Wennemuth, P. Barth, M. Nain, Y. Al-Abed, A. Meinhardt, D. Gemsa, and M. Bacher. 2002 Release of macrophage migration inhibitory factor and CXCL8/interleukin-8 from lung epithelial cells rendered necrotic by influenza A virus infection. J. Virol. 76:9298.
7. Calandra, T., J. Bernhagen, C. N. Metz, L. A. Spiegel, M. Bacher, T. Donnelly, A. Cerami, and R. Bucala. 1995. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377:68.
8. Mitchell, R. A., H. Liao, J. Chesney, G. Fingerle-Rowson, J. Baugh, J. David, and R. Bucala. 2002. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc. Natl. Acad. Sci. USA 99:345.
9. Calandra, T., B. Echtenacher, D. L. Roy, J. Pugin, C. N. Metz, L. Hultner, D. Heumann, D. Mannel, R. Bucala, and M. P. Glauser. 2000. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat. Med. 6:164.
10. Bozza, M., A. R. Satoskar, G. Lin, B. Lu, A. A. Humbles, C. Gerard, and J. R. David. 1999. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J. Exp. Med. 189:341.
11. Gando, S., J. Nishihira, S. Kobayashi, Y. Morimoto, S. Nanzaki, and O. Kemmotsu. 2001. Macrophage migration inhibitory factor is a critical mediator of systemic inflammatory response syndrome. Intens. Care Med. 27:1187.
12. Riedemann, N. C., R. F. Guo, and P. A. Ward. 2003. Novel strategies for the treatment of sepsis. Nat. Med. 9:517.
13. Huber-Lang, M. S., N. C. Riedeman, J. V. Sarma, E. M. Younkin, S. R. McGuire, I. J. Laudes, K. T. Lu, R. F. Guo, T. A. Neff, V. Padgaonkar, et al. 2002. Protection of innate immunity by C5aR antagonist in septic mice. FASEB J. 16:1567.
14. Riedemann, N. C., R. F. Guo, T. A. Neff, I. J. Laudes, K. A. Keller, V. J. Sarma, M. M. Markiewski, D. Mastellos, C. W. Strey, C. L. Pierson, et al. 2002. Increased C5a receptor expression in sepsis. J. Clin. Invest. 110:101.
15. Czermak, B. J., V. Sarma, C. L. Pierson, R. L. Warner, M. Huber-Lang, N. M. Bless, H. Schmal, H. P. Friedl, and P. A. Ward. 1999. Protective effects of C5a blockade in sepsis. Nat. Med. 5:788.
16. Nakae, H., S. Endo, K. Inada, T. Takakuwa, T. Kasai, and M. Yoshida. 1994. Serum complement levels and severity of sepsis. Res. Commun. Chem. Pathol. Pharmacol. 84:189.
17. Guo, R. F., N. C. Riedemann, K. D. Bernacki, J. V. Sarma, I. J. Laudes, F. S. Zetoune, J. Reuben, E. M. Younkin, T. A. Neff, J. D. Paulaskis, et al. 2003. Neutrophil C5a receptor and the outcome in a rat model of sepsis. FASEB J. 13:1889.
18. Riedemann, N. C., R. F. Guo, K. D. Bernacki, J. Reuben, I. J. Laudes, T. A. Neff, H. Gao, C. Speyer, J. V. Sarma, F. S. Zetoune, et al. 2003. Regulation by C5a of neutrophil activation during sepsis. Immunity 19:193.
19. Guo, R. F., M. Huber-Lang, X. Wang, V. Sarma, V. A. Padgaonkar, R. A. Craig, N. C. Riedemann, S. D. McClintock, T. Hlaing, M. M. Shi, et al. 2000. Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis. J. Clin. Invest. 106: 1271.
20. Huang, X. R., C. W. Chun Hui, Y. X. Chen, B. C. Wong, P. C. Fung, C. Metz, C. H. Cho, W. M. Hui, R. Bucala, S. K. Lam, et al. 2001. Macrophage migration inhibitory factor is an important mediator in the pathogenesis of gastric inflammation in rats. Gastroenterology 121:619.
21. Satoskar, A. R., M. Bozza, M. Rodriguez Sosa, G. Lin, and J. R. David. 2001. Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection. Infect. Immun. 69:906.
22. Koebernick, H., L. Grode, J. R. David, W. Rohde, M. S. Rolph, H. W. Mittrucker, and S. H. Kaufmann. 2002. Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium. Proc. Natl. Acad. Sci. USA 99:13681.
23. Calandra, T., L. A. Spiegel, C. N. Metz, and R. Bucala. 1998. Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria. Proc. Natl. Acad. Sci. USA 95:11383.
24. Lai, K. N., J. C. Leung, C. N. Metz, F. M. Lai, R. Bucala, and H. Y. Lan. 2003. Role for macrophage migration inhibitory factor in acute respiratory distress syndrome. J. Pathol. 199:496.
25. Fingerle-Rowson, G., P. Koch, R. Bikoff, X. Lin, C. N. Metz, F. S. Dhabhar, A. Meinhardt, and R. Bucala. 2003. Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo. Am. J. Pathol. 162:47.
26. Roger, T., J. David, M. P. Glauser, and T. Calandra. 2001. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414:920.
27. Perianayagam, M. C., V. S. Balakrishnan, A. J. King, B. J. Pereira, and B. L. Jaber. 2002. C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway. Kidney Int. 61:456.
28. Hannigan, M., L. Zhan, Z. Li, Y. Ai, D. Wu, and C. K. Huang. 2002. Neutrophils lacking phosphoinositide 3-kinase γ show loss of directionality during N-formyl-Met-Leu-Phe-induced chemotaxis. Proc. Natl. Acad. Sci. USA 99:3603.
29. Hirsch, E., V. L. Katanaev, C. Garlanda, O. Azzolino, L. Pirola, L. Silengo, S. Sozzani, A. Mantovani, F. Altruda, and M. P. Wymann. 2000. Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation. Science 287:1049.